TP53 and metabolic disease: Because p53 signalling has also been implicated in obesity, a better mechanistic understanding of how p53 regulates metabolic flexibility and energy conservation in skeletal muscle could shed light on novel therapeutic targets in metabolic disease, cancer, and sarcopenia.